Daping Hospital
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yang, Zhenzhou
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Recruiting
3
522
RoW
D-1553 Tablet, Docetaxel injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
10/26
12/27
NCT05548348: First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation

Recruiting
2
30
RoW
Furmonertinib 160 mg, Q.D., AST2818 160 mg, Q.D.
Chongqing University Cancer Hospital, Army Specialty Medical Center, The Second Affilicated Hospital of Chongqing Medical University
Non-small Cell Lung Cancer, EGFR G719X, EGFR L861Q, EGFR S768I
12/23
10/25
NCT06020066: SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI

Recruiting
2
202
RoW
EGFR-TK Inhibitor, Stereotactic radiotherapy
Fudan University
Brain Metastases, Non-small Cell Lung Cancer
08/28
08/29

Download Options